Active

[EXAMPLE] Immune Checkpoint Inhibitor Cardiac Monitoring Study

Study period 2024 to 2027
Funder Cancer Institute NSW

A prospective study monitoring cardiac function in patients receiving immune checkpoint inhibitor therapy.

Objectives

  • Characterise the incidence of checkpoint-inhibitor myocarditis
  • Establish a monitoring protocol for at-risk patients

Methodology

Combined cardiac MRI, serial troponin and ECG surveillance across the treatment course.

Back to Funded Studies

Get in Touch

Interested in collaborating with us or learning more about our research? We’d love to hear from you.

Contact Us